{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n ITFG1‐AS1 is a long noncoding RNA that appears to play an important regulatory role in cancer biology. In the study detailed in"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ", ITFG1‐AS1 was found to be downregulated in tumor tissues, and its decreased expression was associated with enhanced cell proliferation and migration, as well as poorer clinical outcomes. Mechanistic analyses suggest that ITFG1‐AS1 may act as a competing endogenous RNA by sequestering specific microRNAs, thereby modulating the expression of downstream target genes that drive oncogenic processes. These findings support the concept that ITFG1‐AS1 not only contributes to the molecular events underlying tumor progression but also holds promise as a prognostic biomarker and potential therapeutic target.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Lianghua Luo, Leyan Li, Li Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Genet (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fgene.2022.833928"}], "href": "https://doi.org/10.3389/fgene.2022.833928"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35330731"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35330731"}]}]}]}